Market Commentary - Stock Alert
Titan Company, Indigo, Mankind Pharma in spotlight As on : 03-Aug-23  08:18

Titan Company: Titan Company reported 4% fall in consolidated net profit to Rs 756 crore in Q1 FY24 as against a net profit of Rs 790 crore in Q1 FY23. Total income rose 21% to Rs 11070 crore in the quarter ended 30 June 2023 from Rs 9131 crore recorded in Q1 FY23.

Vedanta: Twin Star, a company promoted by Anil Agarwal, is planning to sell off 4.3% stake through block deal in Vedanta to raise up to $501 million (Rs 4,136 crore) for debt repayment.

JSW Steel: The company has entered into a joint venture agreement with JFE Steel Corporation (JFE) for the purposes of establishing a joint venture company in India (JVC) for the manufacture and sale of CRGO using industry leading machinery, technical know-how and JFE Steel's energy efficient production technology developed through extensive R&D.

InterGlobe Aviation (Indigo): Indigo reported a consolidated net profit of Rs 3,090.60 crore in Q1 FY24 as against a net loss of Rs 1,064.26 crore in Q1 FY23. Revenue from operations jumped 29.78% to Rs 16,683.05 crore in the quarter ended 30 June 2023 from Rs 12,855.29 crore recorded in Q1 FY23.

Mankind Pharma: Mankind Pharma reported 66% surge in consolidated net profit to Rs 494 crore in Q1 FY24 as against a net profit of Rs 298 crore in Q1 FY23. Revenue from operations jumped 18% to Rs 2579 crore in the quarter ended 30 June 2023 from Rs 2180 crore recorded in Q1 FY23.

Metropolis Healthcare: The company reported consolidated net profit of Rs 29 crore in Q1 FY24 as against a net profit of Rs 34 crore in Q1 FY23. Revenue from operations fell to Rs 277 crore in the quarter ended 30 June 2023 from Rs 280 crore recorded in Q1 FY23.

Powered by Capital Market - Live News